Paul Bowness
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue.
Journal: Annals of the rheumatic diseases
Published: March 14, 2025
Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive protein.
Journal: bioRxiv : the preprint server for biology
Published: January 27, 2025
HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity.
Journal: Nature reviews. Rheumatology
Published: November 06, 2024
Pathogenic T-cell clones in axial spondyloarthritis: what is the evidence?
Journal: Rheumatology (Oxford, England)
Published: July 23, 2024
Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor.
Journal: Bioengineered
Published: January 07, 2024
Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.
Journal: Frontiers in immunology
Published: December 14, 2023
Elevated type-17 cytokines are present in axial spondyloarthritis stool.
Journal: Discovery immunology
Published: November 22, 2023
Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Journal: BMJ open
Published: September 28, 2023
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis.
Journal: JCI insight
Published: August 15, 2023
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.
Journal: Science translational medicine
Published: July 26, 2023
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Rheumatology
Published: June 29, 2023
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis.
Journal: Cell genomics
Published: April 29, 2022
Last Updated: 09/26/2026